Skip to main content
. 2022 Jan 13;8:759648. doi: 10.3389/fmed.2021.759648

Table 2.

Association of blood type characteristics to noncritical vs. critical coronavirus disease 2019 (COVID-19) hospital presentation.

Prevalence (%) Unadjusted Adjusted*
Non-critical (n = 341) Critical (n = 186) p-value Odds ratio (95% CI) p-value Odds ratio (95% CI) p-value
Blood type 0.007
A 95 (27.9%) 65 (34.9%) 1.39 (0.95, 2.04) 0.091 1.46 (0.95, 2.25) 0.086
B 77 (22.6%) 57 (30.6%) 1.52 (1.00, 2.26) 0.048 1.50 (0.96, 1.65) 0.068
AB 23 (6.7%) 12 (6.5%) 0.95 (0.46, 1.96) 0.897 0.78 (0.35, 1.81) 0.575
O 146 (42.8%) 52 (28.0%) 0.52 (0.33, 0.76) 0.001** 0.51 (0.33, 0.79) 0.003**
Anti-A antibodies 0.090 0.091 0.080
No 95 (29.9%) 65 (37.4%) 1.00 1.00
Yes 223 (70.1%) 109 (62.6%) 0.71 (0.48, 1.05) 0.67 (0.43, 1.05)
Anti-B antibodies 0.042 0.042 0.163
No 77 (24.2%) 57 (32.8%) 1.00 1.00
Yes 241 (75.8%) 117 (67.2%) 0.65 (0.43, 0.98) 0.72 (0.45, 1.14)
A antigen 0.123 0.123 0.144
No 223 (65.4%) 109 (58.6%) 1.00 1.00
Yes 118 (34.6%) 77 (41.4%) 1.33 (0.92, 1.92) 1.36 (0.89, 2.06)
B antigen 0.068 0.068 0.275
No 241 (70.7%) 117 (62.9%) 1.00 1.00
Yes 100 (29.3%) 69 (37.1%) 1.42 (0.97, 2.07) 1.27 (0.82, 1.95)
Rh factor 0.706 0.706 0.817
Positive 316 (92.7%) 174 (93.5%) 1.00 1.00
Negative 25 (7.3%) 12 (6.5%) 1.14 (0.56, 2.34) 1.09 (0.49, 2.43)
*

Adjusted for age, gender, body mass index (BMI), and presence of comorbid conditions;

**

significant association.